Renata Limited (formerly Pfizer Limited) is one of the leading and fastest growing pharmaceutical and animal health product companies in Bangladesh. The company started its operations in 1972 as Pfizer (Bangladesh) Limited. In 1993, Pfizer transferred the ownership of its Bangladesh operations to local shareholders and the name of the company was changed to Renata Limited.
The core businesses of Renata Limited are human pharmaceuticals and animal health products. In Bangladesh it is the 4th largest pharmaceutical company and the market leader in animal health products. In addition, Renata products are exported to Afghanistan, Belize, Cambodia, Ethiopia, Guyana, Honduras, Hong Kong, Kenya, Malaysia, Myanmar, Nepal, Philippines, Sri Lanka, Thailand, United Kingdom, and Vietnam. The Company is listed on the Dhaka Stock Exchange with market capitalization of approximately Taka 50 billion.
The Company has eight manufacturing facilities spread over three manufacturing sites. In addition Renata Oncology Limited has two manufacturing facilities. Distribution of products is carried out by 19 depots across the country.
Renata employs 4,334 people.
- Focus on Long-Term Growth
- Structural Innovation for Sharing Growth
- Going the Extra Mile for Employees
- Environmental Activism
- Health Activism through Promoting Innovation and Partnerships
Corporate Social Responsibility
To Renata, corporate social responsibility (CSR) means caring for our employees, assisting disadvantaged members of our society, and building a sustainable environment. read more
There are three subsidiaries of Renata Limited, viz., Renata Agro Industries Limited, Purnava Limited, and Renata Oncology Limited. read more